Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4517261000168114 | Kabiven G19% (alanine 7.2 g / 1.54 L + arginine 5.1 g / 1.54 L + aspartic acid 1.5 g / 1.54 L + calcium chloride dihydrate 440 mg / 1.54 L + glutamic acid 2.5 g / 1.54 L + glycine 3.6 g / 1.54 L + histidine 3.1 g / 1.54 L + isoleucine 2.5 g / 1.54 L + leucine 3.6 g / 1.54 L + lysine hydrochloride 5.1 g / 1.54 L + magnesium sulfate heptahydrate 1.5 g / 1.54 L + methionine 2.5 g / 1.54 L + phenylalanine 3.6 g / 1.54 L + potassium chloride 2.7 g / 1.54 L + proline 3.1 g / 1.54 L + serine 2 g / 1.54 L + sodium acetate trihydrate 3.7 g / 1.54 L + sodium glycerophosphate 2.3 g / 1.54 L + threonine 2.5 g / 1.54 L + tryptophan 860 mg / 1.54 L + tyrosine 100 mg / 1.54 L + valine 3.3 g / 1.54 L) injection [1 x 450 mL chamber] (&) (glucose 150 g / 1.54 L) injection [1 x 790 mL chamber] (&) (soya oil 60 g / 1.54 L) injection [1 x 300 mL chamber], 4 x 1.54 L multi-chamber bags (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4517271000168115 | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | Is a | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | has container type | multi-chamber bag | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | has TP | Kabiven G19% | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | has TPUU | Kabiven G19% Glucose 150 g/1.54 L injection, 790 mL chamber | true | Inferred relationship | Some | 785624772 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | has TPUU | Kabiven G19% Intralipid 60 g/1.54 L injection, 300 mL chamber | true | Inferred relationship | Some | 1508769563 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | has TPUU | Kabiven G19% Vamin 18 Novum injection, 450 mL chamber | true | Inferred relationship | Some | 1925163902 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 1.54 L multi-chamber bags | has subpack | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 1.54 L multi-chamber bag | true | Inferred relationship | Some | 1014365160 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR